Delivery Order SPE2DB22D3011-SPE2DB25FP7NG

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB25D3018|SPE2DB25FUXAJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $2,265.90 and a final completion date of March 18, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPT41, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Humira (CF) Pen 80 mg/0.8 mL, a pharmaceutical product. The contract has a ceiling value of $2,791.68 and a period of performance through March 4, 2025. It is a firm-fixed-price delivery order contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX8EF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $45,082.30, is a Firm Fixed Price Delivery Order for the supply of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical...
This federal contract award SPE2DB20D3103|SPE2DB25FL3Q5, valued at $6,545.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of October 16, 2024. The contract does not have a set-aside designation, indicating...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FTP26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,911.04 delivery order contract is for the supply of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products. The contract has a firm fixed price and an ultimate completion date of November 22, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FY56G, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $11,458.56 and a performance period ending on October 17, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen Drug Corp is a major...
This federal contract award, identified as SPE2DB20D1109|SPE2DB25FN57B, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award has a ceiling value of $1,510.60 and a completion date of February 18, 2025. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, and is a Firm Fixed Price (FFP) Delivery Order. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,265.75 firm fixed price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of June 25, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
The federal contract award SPE2DB22D2007|SPE2DB25FH7LZ was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,446.43 Firm Fixed Price Delivery Order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the...
This federal contract award, identified as SPE2DX15D1022|SPE2DX25FUZHR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $11,082.96 and a completion date of November 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP7NG
    Delivery Order

This federal contract award SPE2DB22D3011|SPE2DB25FP7NG was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products, with a ceiling value of $25,189.36 and an ultimate completion date of October 31, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:17 PM